Juan Michael Porter II, a prominent healthcare journalist and HIV advocate, spoke to MHE about keeping HIV/AIDS a priority and the dynamics of funding programs and pharmaceutical pricing
Second of two parts
Juan Michael Porter II, a senior editor at
In a video interview with Managed Healthcare Executive recorded before the meeting, Porter discussed the prospect of cuts in the funding of HIV treatment and prevention programs, particularly the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Porter referenced arguments made by Francoise Barre-Sinoussi, who was part of the team that won a Nobel Prize for identifying HIV as the cause of AIDS, that links funding issues to linked to prices set by pharmaceutical companies. Porter also expressed trust that Jeanne Marrazzo, M.D., M.P.H., director of the National Institute of Allergy and Infectious Diseases would keep HIV/AIDS a priority.
